Viral infections affecting the liver have had an important impact on humanity, as they have
led to significant morbidity and mortality in patients with acute and chronic infections. Once …

Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …

Hepatitis delta virus (HDV) is a defective virus and a satellite of the hepatitis B virus (HBV).
Its RNA genome is unique among animal viruses, but it shares common features with some …

Hepatitis delta virus (HDV) is a sub-viral agent that is dependent for its life cycle on hepatitis
B virus (HBV). The help it obtains from HBV is limited to the sharing of envelope proteins …

Hepatitis delta virus (HDV) infection of humans was first reported in 1977, and now it is now
estimated that 15–20 million people are infected worldwide. Infection with HDV can be an …

Twenty-five years ago Rizzetto et al.[1], while examining liver biopsies from individuals
infected with HBV, discovered by immunofluorescence a previously unrecognized nuclear …

HDV is a defective RNA pathogen requiring the simultaneous presence of HBV to complete
its life cycle. Two major specific patterns of infection have been described: the coinfection …

Hepatitis D virus (HDV) infection involves a distinct subgroup of individuals simultaneously
infected with the hepatitis B virus (HBV) and characterized by an often severe chronic liver …

Liver transplantation for liver diseases related to hepatitis B virus (HBV) and hepatitis delta
virus (HDV) remains problematic because of the risk of viral recurrence. We report here the …

Chronic delta hepatitis is the most severe form of viral hepatitis affecting nearly 65 million
people worldwide. Individuals with this devastating illness are at higher risk for developing …